Skip to main content
Erschienen in: Herz 4/2020

27.07.2018 | Original articles

What physicians do in case of a failure of the pace-sense part of a defibrillation lead

Survey in Germany, Austria and Switzerland

verfasst von: P. Lacour, A. Parwani, M. Huemer, P. Attanasio, P. L. Dang, J. Luebcke, L. Schleussner, D. Blaschke, L.-H. Boldt, B. Pieske, W. Haverkamp, PD Dr. F. Blaschke

Erschienen in: Herz | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

The possible treatment strategies for defects of the pace-sense (P/S) part of a defibrillation lead are either implantation of a new high-voltage (HV)-P/S lead, with or without extraction of the malfunctioning lead, or implantation of a P/S lead.

Methods

We conducted a Web-based survey across cardiac implantable electronic device (CIED) centers to investigate their procedural practice and decision-making process in cases of failure of the P/S portion of defibrillation leads. In particular, we focused on the question of whether the integrity of the HV circuit is confirmed by a test shock before decision-making. The questionnaire included 14 questions and was sent to 951 German, 341 Austrian, and 120 Swiss centers.

Results

The survey was completed by 183 of the 1412 centers surveyed (12.7% response rate). Most centers (90.2%) do not conduct a test shock to confirm the integrity of the HV circuit before decision-making. Procedural practice in lead management varies depending on the presentation of lead failure and whether the center applies a test shock. In centers that do not conduct a test shock, the majority (69.9%) implant a new HV-P/S lead. Most centers (61.7%) that test the integrity of the HV system implant a P/S lead. The majority of centers favor DF-4 connectors (74.1%) over DF-1 connectors (25.9%) at first CIED implantation.

Conclusion

Either implanting a new HV-P/S lead or placing an additional P/S lead are selected strategies if the implantable cardioverter-defibrillator lead failure is localized to the P/S portion. However, conducting a test shock to confirm the integrity of the HV component is rarely performed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Padeletti L, Mascioli G, Perini AP, Grifoni G, Perrotta L, Marchese P, Bontempi L, Curnis A (2011) Critical appraisal of cardiac implantable electronic devices: complications and management. Med Devices (Auckl) 4:157–167 Padeletti L, Mascioli G, Perini AP, Grifoni G, Perrotta L, Marchese P, Bontempi L, Curnis A (2011) Critical appraisal of cardiac implantable electronic devices: complications and management. Med Devices (Auckl) 4:157–167
2.
Zurück zum Zitat Kawada S, Nishii N, Morimoto Y, Miyoshi A, Tachibana M, Sugiyama H, Nakagawa K, Watanabe A, Morita H, Ito H (2017) Comparison of longevity and clinical outcomes of implantable cardioverter-defibrillator leads among manufacturers. Heart Rhythm 14(10):1496–1503CrossRef Kawada S, Nishii N, Morimoto Y, Miyoshi A, Tachibana M, Sugiyama H, Nakagawa K, Watanabe A, Morita H, Ito H (2017) Comparison of longevity and clinical outcomes of implantable cardioverter-defibrillator leads among manufacturers. Heart Rhythm 14(10):1496–1503CrossRef
3.
Zurück zum Zitat Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of > 10 years. Circulation 115(19):2474–2480CrossRef Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of > 10 years. Circulation 115(19):2474–2480CrossRef
4.
Zurück zum Zitat Swerdlow CD, Kalahasty G, Ellenbogen KA (2016) Implantable cardiac defibrillator lead failure and management. J Am Coll Cardiol 67(11):1358–1368CrossRef Swerdlow CD, Kalahasty G, Ellenbogen KA (2016) Implantable cardiac defibrillator lead failure and management. J Am Coll Cardiol 67(11):1358–1368CrossRef
5.
Zurück zum Zitat Eckstein J, Koller MT, Zabel M, Kalusche D, Schaer BA, Osswald S, Sticherling C (2008) Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation 117(21):2727–2733CrossRef Eckstein J, Koller MT, Zabel M, Kalusche D, Schaer BA, Osswald S, Sticherling C (2008) Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation 117(21):2727–2733CrossRef
6.
Zurück zum Zitat van Rees JB, van Welsenes GH, Borleffs CJ, Thijssen J, van der Velde ET, van der Wall EE, van Erven L, Schalij MJ (2012) Update on small-diameter implantable cardioverter-defibrillator leads performance. Pacing Clin Electrophysiol 35(6):652–658CrossRef van Rees JB, van Welsenes GH, Borleffs CJ, Thijssen J, van der Velde ET, van der Wall EE, van Erven L, Schalij MJ (2012) Update on small-diameter implantable cardioverter-defibrillator leads performance. Pacing Clin Electrophysiol 35(6):652–658CrossRef
7.
Zurück zum Zitat Providencia R, Kramer DB, Pimenta D, Babu GG, Hatfield LA, Ioannou A, Novak J, Hauser RG, Lambiase PD (2015) Transvenous Implantable Cardioverter-Defibrillator (ICD) lead performance: a meta-analysis of observational studies. J Am Heart Assoc 4(11):e2418CrossRef Providencia R, Kramer DB, Pimenta D, Babu GG, Hatfield LA, Ioannou A, Novak J, Hauser RG, Lambiase PD (2015) Transvenous Implantable Cardioverter-Defibrillator (ICD) lead performance: a meta-analysis of observational studies. J Am Heart Assoc 4(11):e2418CrossRef
8.
Zurück zum Zitat Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M, Remp T, Durchlaub I, Gerth A, Steinbeck G, Hoffmann E (2003) Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol 14(1):38–43CrossRef Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M, Remp T, Durchlaub I, Gerth A, Steinbeck G, Hoffmann E (2003) Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol 14(1):38–43CrossRef
9.
Zurück zum Zitat Holubec T, Ursprung G, Schonrath F, Caliskan E, Steffel J, Falk V, Benussi S, Maisano F, Starck CT (2015) Does implantation technique influence lead failure? Acta Cardiol 70(5):581–586CrossRef Holubec T, Ursprung G, Schonrath F, Caliskan E, Steffel J, Falk V, Benussi S, Maisano F, Starck CT (2015) Does implantation technique influence lead failure? Acta Cardiol 70(5):581–586CrossRef
10.
Zurück zum Zitat Krahn AD, Champagne J, Healey JS, Cameron D, Simpson CS, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Parkash R, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Essebag V, Canadian Heart Rhythm Society Device Advisory C (2008) Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm 5(5):639–642CrossRef Krahn AD, Champagne J, Healey JS, Cameron D, Simpson CS, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Parkash R, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Essebag V, Canadian Heart Rhythm Society Device Advisory C (2008) Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm 5(5):639–642CrossRef
11.
Zurück zum Zitat Parkash R, Tung S, Champagne J, Healey JS, Thibault B, Cameron D, Tang A, Connors S, Beardsall M, Mangat I, Ayala-Paredes F, Toal S, Exner D, Yee R, Krahn AD (2015) Insight into the mechanism of failure of the Riata lead under advisory. Heart Rhythm 12(3):574–579CrossRef Parkash R, Tung S, Champagne J, Healey JS, Thibault B, Cameron D, Tang A, Connors S, Beardsall M, Mangat I, Ayala-Paredes F, Toal S, Exner D, Yee R, Krahn AD (2015) Insight into the mechanism of failure of the Riata lead under advisory. Heart Rhythm 12(3):574–579CrossRef
12.
Zurück zum Zitat Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM 3rd, Hayes DL (2005) Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol 45(10):1672–1675CrossRef Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM 3rd, Hayes DL (2005) Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol 45(10):1672–1675CrossRef
13.
Zurück zum Zitat Polewczyk A, Kutarski A, Tomaszewski A, Brzozowski W, Czajkowski M, Polewczyk M, Janion M (2013) Lead dependent tricuspid dysfunction: analysis of the mechanism and management in patients referred for transvenous lead extraction. Cardiol J 20(4):402–410CrossRef Polewczyk A, Kutarski A, Tomaszewski A, Brzozowski W, Czajkowski M, Polewczyk M, Janion M (2013) Lead dependent tricuspid dysfunction: analysis of the mechanism and management in patients referred for transvenous lead extraction. Cardiol J 20(4):402–410CrossRef
14.
Zurück zum Zitat Buiten MS, van der Heijden AC, Schalij MJ, van Erven L (2015) How adequate are the current methods of lead extraction? A review of the efficiency and safety of transvenous lead extraction methods. Europace 17(5):689–700CrossRef Buiten MS, van der Heijden AC, Schalij MJ, van Erven L (2015) How adequate are the current methods of lead extraction? A review of the efficiency and safety of transvenous lead extraction methods. Europace 17(5):689–700CrossRef
15.
Zurück zum Zitat Wollmann CG, Bocker D, Loher A, Kobe J, Scheld HH, Breithardt GE, Gradaus R (2005) Incidence of complications in patients with implantable cardioverter/defibrillator who receive additional transvenous pace/sense leads. Pacing Clin Electrophysiol 28(8):795–800CrossRef Wollmann CG, Bocker D, Loher A, Kobe J, Scheld HH, Breithardt GE, Gradaus R (2005) Incidence of complications in patients with implantable cardioverter/defibrillator who receive additional transvenous pace/sense leads. Pacing Clin Electrophysiol 28(8):795–800CrossRef
16.
Zurück zum Zitat Scott PA, Chungh A, Zeb M, Yue AM, Roberts PR, Morgan JM (2010) Is the use of an additional pace/sense lead the optimal strategy for the avoidance of lead extraction in defibrillation lead failure? A single-centre experience. Europace 12(4):522–526CrossRef Scott PA, Chungh A, Zeb M, Yue AM, Roberts PR, Morgan JM (2010) Is the use of an additional pace/sense lead the optimal strategy for the avoidance of lead extraction in defibrillation lead failure? A single-centre experience. Europace 12(4):522–526CrossRef
17.
Zurück zum Zitat Swerdlow CD, Ellenbogen KA (2013) Implantable cardioverter-defibrillator leads: design, diagnostics, and management. Circulation 128(18):2062–2071CrossRef Swerdlow CD, Ellenbogen KA (2013) Implantable cardioverter-defibrillator leads: design, diagnostics, and management. Circulation 128(18):2062–2071CrossRef
18.
Zurück zum Zitat Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, Cha YM, Clancy J, Deharo JC, Ellenbogen KA, Exner D, Hussein AA, Kennergren C, Krahn A, Lee R, Love CJ, Madden RA, Mazzetti HA, Moore JC, Parsonnet J, Patton KK, Rozner MA, Selzman KA, Shoda M, Srivathsan K, Strathmore NF, Swerdlow CD, Tompkins C, Wazni O (2017) 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm 14(12):e503–e551CrossRef Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, Cha YM, Clancy J, Deharo JC, Ellenbogen KA, Exner D, Hussein AA, Kennergren C, Krahn A, Lee R, Love CJ, Madden RA, Mazzetti HA, Moore JC, Parsonnet J, Patton KK, Rozner MA, Selzman KA, Shoda M, Srivathsan K, Strathmore NF, Swerdlow CD, Tompkins C, Wazni O (2017) 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm 14(12):e503–e551CrossRef
19.
Zurück zum Zitat Koneru JN, Gunderson BD, Sachanandani H, Wohl BN, Kendall KT, Swerdlow CD, Ellenbogen KA (2013) Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads. Heart Rhythm 10(6):813–818CrossRef Koneru JN, Gunderson BD, Sachanandani H, Wohl BN, Kendall KT, Swerdlow CD, Ellenbogen KA (2013) Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads. Heart Rhythm 10(6):813–818CrossRef
20.
Zurück zum Zitat Hauser RG, McGriff D, Retel LK (2012) Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect. Heart Rhythm 9(5):742–749CrossRef Hauser RG, McGriff D, Retel LK (2012) Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect. Heart Rhythm 9(5):742–749CrossRef
21.
Zurück zum Zitat Leong DP, van Erven L (2012) Unrecognized failure of a narrow caliber defibrillation lead: the role of defibrillation threshold testing in identifying an unprotected individual. Pacing Clin Electrophysiol 35(6):e154–e155CrossRef Leong DP, van Erven L (2012) Unrecognized failure of a narrow caliber defibrillation lead: the role of defibrillation threshold testing in identifying an unprotected individual. Pacing Clin Electrophysiol 35(6):e154–e155CrossRef
22.
Zurück zum Zitat Wutzler A, Attanasio P, Haverkamp W, Blaschke F (2016) Near-fatal ICD lead dysfunction with implications for ICD testing. Pacing Clin Electrophysiol 39(1):105–106CrossRef Wutzler A, Attanasio P, Haverkamp W, Blaschke F (2016) Near-fatal ICD lead dysfunction with implications for ICD testing. Pacing Clin Electrophysiol 39(1):105–106CrossRef
23.
Zurück zum Zitat Hauser RG, Abdelhadi R, McGriff D, Retel LK (2012) Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm 9(8):1227–1235CrossRef Hauser RG, Abdelhadi R, McGriff D, Retel LK (2012) Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm 9(8):1227–1235CrossRef
24.
Zurück zum Zitat Shah P, Singh G, Chandra S, Schuger CD (2013) Failure to deliver therapy by a Riata Lead with internal wire externalization and normal electrical parameters during routine interrogation. J Cardiovasc Electrophysiol 24(1):94–96CrossRef Shah P, Singh G, Chandra S, Schuger CD (2013) Failure to deliver therapy by a Riata Lead with internal wire externalization and normal electrical parameters during routine interrogation. J Cardiovasc Electrophysiol 24(1):94–96CrossRef
25.
Zurück zum Zitat Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, Epstein LM, Friedman RA, Kennergren CE, Mitkowski P, Schaerf RH, Wazni OM, Heart Rhythm S, American Heart A (2009) Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 6(7):1085–1104CrossRef Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, Epstein LM, Friedman RA, Kennergren CE, Mitkowski P, Schaerf RH, Wazni OM, Heart Rhythm S, American Heart A (2009) Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 6(7):1085–1104CrossRef
26.
Zurück zum Zitat Higgins JV, Gard JJ, Sheldon SH, Espinosa RE, Wood CP, Felmlee JP, Cha YM, Asirvatham SJ, Dalzell C, Acker N, Watson RE Jr., Friedman PA (2014) Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads. Pacing Clin Electrophysiol 37(10):1284–1290CrossRef Higgins JV, Gard JJ, Sheldon SH, Espinosa RE, Wood CP, Felmlee JP, Cha YM, Asirvatham SJ, Dalzell C, Acker N, Watson RE Jr., Friedman PA (2014) Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads. Pacing Clin Electrophysiol 37(10):1284–1290CrossRef
27.
Zurück zum Zitat Austin CO, Landolfo K, Parikh PP, Patel PC, Venkatachalam KL, Kusumoto FM (2017) Retained cardiac implantable electronic device fragments are not associated with magnetic resonance imaging safety issues, morbidity, or mortality after orthotopic heart transplant. Am Heart J 190:46–53CrossRef Austin CO, Landolfo K, Parikh PP, Patel PC, Venkatachalam KL, Kusumoto FM (2017) Retained cardiac implantable electronic device fragments are not associated with magnetic resonance imaging safety issues, morbidity, or mortality after orthotopic heart transplant. Am Heart J 190:46–53CrossRef
Metadaten
Titel
What physicians do in case of a failure of the pace-sense part of a defibrillation lead
Survey in Germany, Austria and Switzerland
verfasst von
P. Lacour
A. Parwani
M. Huemer
P. Attanasio
P. L. Dang
J. Luebcke
L. Schleussner
D. Blaschke
L.-H. Boldt
B. Pieske
W. Haverkamp
PD Dr. F. Blaschke
Publikationsdatum
27.07.2018
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 4/2020
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-018-4736-9

Weitere Artikel der Ausgabe 4/2020

Herz 4/2020 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.